Merck & Co., Inc. (NYSE:MRK) registered a 0.90% increase, still its new closing price is 32.88% up from the company’s 1 year high of 64.96.It posted -1.25% losses in previous 5 sessions and is now the subject of 7 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 1 sells versus 4 buy or better ratings. The shares moved at $61.75, implying that brokerage firms see shares gaining about 29.56% in twelve months time.
Merck & Co., Inc. (MRK) SEC Form 4 News
The stock is getting much attention these days as insiders are offloading shares while they posted a 4.89% rise year to date. A Chairman, President & CEO at Merck & Co., Inc. (MRK) offloaded shares in a transaction closed on Thursday November 10, 2016. FRAZIER KENNETH C sold 140,000 shares in the company at $65.03 each and collected $9,104,000 in proceeds. FRAZIER KENNETH C now owns 512,628 shares in the company after this transaction. A EVP Strat Comm, Gl Pub Policy in the company, Gerberding Julie L., disclosed a transaction on Monday November 07, 2016 that ended up generating $5,133,000 from the sale of 85,523 shares at $60.02 per share.
Merck & Co., Inc. (NYSE:MRK) Upcoming Results on Tap
Merck & Co., Inc. will next provide financial results for the March 2017 quarter. Stock analysts expect it to report per-share earnings of $0.91 in that period. Sales during the quarter are predicted to arrive at $9.48 billion.
Earnings surprise history: Last quarter, the company posted approximately $10.54 billion in revenue and EPS of $1.07. The mean forecast was for $10.18 billion and $0.99 a share, respectively. One quarter earlier, revenue for the stock was at $9.84 billion, with earnings at $0.93/share.
Merck & Co., Inc. (MRK) Brokerage Update
Merck & Co., Inc. (MRK) is in Guggenheim’s research list so their analyst rating change is noteworthy. These shares were upgraded to Buy from Neutral by Guggenheim, according to news reported on Thursday January 12, 2017.Another important research note was issued by Piper Jaffray on Thursday January 12, 2017.The firm upgraded MRK to Overweight from Neutral. Over the last six months and over the last three months, the shares of Merck & Co., Inc. (MRK), have changed 7.27% and 2.22%, respectively.